Lifeward Stock

Lifeward FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Lifeward (LFWD) as of Jul 29, 2026 is 75.04 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 93.74 % — a change of -19.95% (lower).

FCF Conversion

75.04 %

YoY

-19.95%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Lifeward is 2026 75.04 % . FCF Conversion Rate (FCF/EBITDA) of Lifeward was 2025 93.74 % . It decreases by -19.95% lower compared to the previous year.
Access this data via the Eulerpool API

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

FCF Conversion Rate (FCF/EBITDA) of Lifeward is 75.04 % in 2026.

Access this data via the Eulerpool API

Cash Flow — Lifeward

All Key Metrics — Lifeward